Drug Self-Administration Markets to 2018 - Drug Products, Indications, Markets and Forecasts

• Publication date: March 2013

While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered orally. Because they cannot tolerate the first-pass metabolism of the digestive tract, the recent escalation in new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Now a number of factors are converging to create both risk and opportu...

While alternative methods for delivering therapeutics to patients have had some notable successes, most drugs continue to be delivered orally. Because they cannot tolerate the first-pass metabolism of the digestive tract, the recent escalation in new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Now a number of factors are converging to create both risk and opportunity for drug makers and their delivery device partners. These include new classes of drugs for previously refractory conditions, the growing trend toward self-administration for chronic diseases, shifting patient demographics in industrial countries, caregiver safety legislation, and continued pressure to control healthcare costs.

These factors are giving rise to a new generation of sophisticated, application-specific injection, inhalation and transdermal drug products designed to satisfy caregiver and patient preferences while addressing managed care initiatives and the formulation limitations of new classes of therapeutic drugs. Because of their ability to safely and reliably satisfy treatment protocols and compliance goals, non-oral drug delivery products will have a significant impact on the future of drug self-administration.

Highlights

• Provides detailed analysis of drug self-administration market segments, market dynamics and market demographics
• Analyzes therapeutic demand drivers and evaluates commercial drug products in more than two dozen major self-administration therapeutic segments
• Analyzes design factors, material selection issues, technologies and market development issues for injection devices, inhalation devices and transdermal drug products designed for self-administration
• Charts product data, market share, and forecasts to 2018
• Profiles self-administration drug product and device participants, their product development activities, business strategies, and corporate alliances and affiliations

Drug Delivery Technology Industry

Summary of Contents
Executive Summary

The Market Opportunity

Drug Market Dynamics
Evolving Drug Market Factors
Chronic Disease and Self-administration
Managed Care and Prescribing Trends
Drug Self-Administration Demand Factors

Drug Self-Administration Product Segments and Market Drivers

Injectable Drug Self-Administration Products
Prefilled Syringes (PFS)
Pen Injectors
Needle-free Injectors (NFI)

Inhaled Drug Self-Administration Products
The Upper Respiratory Market
The Systemic/Deep Lung Market
Inhaler Product Segments
Dry Powder Inhalers
Metered Dose Inhalers
Nebulizers
Performance Factors

Transdermal Drug Products
Market Sector Dynamics
Prescription Patch Design & Technology
Prescription Patch Development Factors
Key Transdermal Therapeutic Markets
Transdermal Product Company Profiles

Drug Self-Administration – Therapeutic Sector Analysis & Forecasts

ADHD
Anticoagulants
Arthritis
Asthma/COPD
Cardiovascular
Contraception
Cystic Fibrosis
Diabetes
Hematopoietics
Hepatitis
Hormone Therapy/Replacement
Multiple Sclerosis
Neurology
Osteoporosis
Pain Management
Psoriasis
Sexual Health

Company Profiles